货号:GS40729
Tislelizumab is a humanized monoclonal antibody targeting programmed cell death protein 1 (PD-1). Engineered to minimize binding to Fcγ receptors on macrophages, it reduces antibody-dependent phagocytosis of T cells, potentially enhancing anti-tumor activity. It is approved in China and internationally for various cancers, including classical Hodgkin lymphoma, non-small cell lung cancer, and esophageal squamous cell carcinoma.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物